Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Vivione Biosciences Inc
V.VBI.H
Vivione Biosciences Inc. is a holding company which is currently reviewing potential acquisitions. The Company’s subsidiary is Vivione Biosciences, LLC.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:VBI.H)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
Next
(148)
•••
Misbrandt
X
View Profile
View Bullboard History
Post by
Misbrandt
on Feb 21, 2015 4:18am
On the other hand
Major cash burn, dilution almost doubling shares (if it even gets close to closing), little promotion. I guess I can see why this stock is hurting. We might some decent revenue soon though, the
...more
(148)
•••
Misbrandt
X
View Profile
View Bullboard History
Comment by
Misbrandt
on Feb 20, 2015 8:23am
RE:PROMOTION
This might be an unprecedented chance to sneak in on a complete sleeper. If the 100 000 tests per year via Ely actually materialize it would really not surprise me to see this quadruple. That isn'
...more
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
posted Nov 14, 2024 9:00am by
NurExone Biologic Inc.
-
|
“We are honored by the EMA’s recognition of ExoPTEN through the Orphan Medicinal Product Designation, which significantly advances our ability to enter the European market and offers hope to those impacted by acute spinal cord injuries,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This designation, together with the ...read more
(0)
•••
coobn96
X
View Profile
View Bullboard History
Post by
coobn96
on Feb 06, 2015 8:11pm
PROMOTION
is the name of the game with stocks - I have seen co.s with great ideas/products like our VBI or a jr gold miner sit on a solid ore body etc, etc., and the principals are so busy or involved in the
...more
(77)
•••
divot111
X
View Profile
View Bullboard History
Comment by
divot111
on Feb 04, 2015 8:48pm
RE:RE:RE:RE:RE:Looks Like A Win, Seems Like A Win But ...........????
I don't get why the market hasn't jumped on this one? They do have a good product by the sounds of it. Hopefully the PP fills quick then we can go higher. Good luck
(0)
•••
Hawkdog
X
View Profile
View Bullboard History
Comment by
Hawkdog
on Jan 29, 2015 11:24am
RE:RE:RE:RE:Looks Like A Win, Seems Like A Win But ...........????
you called the PP for sure.
(77)
•••
divot111
X
View Profile
View Bullboard History
Comment by
divot111
on Jan 29, 2015 11:18am
RE:revenue and revenue potentials
So aproximately 1 million in revenue last year but potential for 2017 is 20 million? Derr? Why pay 9.5 times earnings for potential? Hmmmm? We'll see.......
(77)
•••
divot111
X
View Profile
View Bullboard History
Comment by
divot111
on Jan 29, 2015 11:15am
RE:RE:RE:Looks Like A Win, Seems Like A Win But ...........????
lol, there is the PP I was telling you about. Dilution is the best solution. Good luck filling it at .35 when the open market price is .20 or lower.
(0)
•••
ALTACRUDE
X
View Profile
View Bullboard History
Comment by
ALTACRUDE
on Jan 28, 2015 12:56pm
RE:revenue and revenue potentials
What will this do for the sale of Rapid B systems.
(0)
•••
Hawkdog
X
View Profile
View Bullboard History
Post by
Hawkdog
on Jan 28, 2015 9:19am
revenue and revenue potentials
The company holds licenses or patents for three biomarkers, including neutrophil CD64, soluble CD163 and circulating cell free DNA. Trillium generated approximately US$1,000,000 in revenue in
...more
(0)
•••
Hawkdog
X
View Profile
View Bullboard History
Post by
Hawkdog
on Jan 28, 2015 9:04am
news out - halted
Vivione Biosciences to acquire Trillium Diagnostics 2015-01-28 07:25 ET - News Release Mr. Kevin Kuykendall reports VIVIONE BIOSCIENCES INC. ANNOUNCES AGREEMENT TO ACQUIRE
...more
(0)
•••
Hawkdog
X
View Profile
View Bullboard History
Comment by
Hawkdog
on Jan 26, 2015 9:51am
RE:RE:Looks Like A Win, Seems Like A Win But ...........????
Did you give management a call? They returned my call immediately. I think the next big thing will be the next step with the clinical trials - i think that's the cash cow for this company -
...more
(77)
•••
divot111
X
View Profile
View Bullboard History
Comment by
divot111
on Jan 24, 2015 1:57pm
RE:Looks Like A Win, Seems Like A Win But ...........????
Looks like they will need money soon? No? They seem to burn through a lot of cash quickly and by the looks of the financials they will be out soon. Research costs money though. I get it. I sold
...more
(0)
•••
Hawkdog
X
View Profile
View Bullboard History
Post by
Hawkdog
on Jan 23, 2015 3:01pm
got some shares
Pick a small position today, seems like this team has some pieces in place to do well
(0)
•••
coobn96
X
View Profile
View Bullboard History
Post by
coobn96
on Jan 21, 2015 11:19pm
Looks Like A Win, Seems Like A Win But ...........????
Once again what appears to be good news based on an advancement of products and success with VBI's systems and obvious hard work behind the scenes is met with nonchalance related to the
...more
(0)
•••
Hawkdog
X
View Profile
View Bullboard History
Post by
Hawkdog
on Jan 21, 2015 5:26pm
news out
Vivione sells Rapid-B unit to AES Water Solutions 2015-01-20 07:17 ET - News Release Mr. Kevin Kuykendall reports VIVIONE BIOSCIENCES INC. ANNOUNCES A STRATEGIC PARTNERSHIP
...more
Prev
1
2
3
4
5
6
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Gold, growth and sustainability in focus for this resource company
Star Diamond Corporation Announces Third Quarter 2024 Results
This $10M Deal Could Reshape the Future of Global Creator Platforms
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Explained: The Psychology of Options Trading with Practical Tips
Meet the Top 5 Best Online Brokerages in Canada
New Gold and Copper Hotspot Identified – What’s Next for This Serbian Project?
Major Funding Secured! Company Closes First Round of Private Placement
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023